Revenue
2023
2024
2025
Radiopharm Theranostics Ltd (RADX)
Price$2.08Cached quote
Financial statements
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | $3.6M | $299,228 | $292,359 | — |
| Gross profit | $39,276 | $299,228 | $292,359 | — |
| Gross margin | 1.08% | 100.00% | 100.00% | — |
| Research & development | $27.5M | $23.1M | $22.6M | — |
| Operating expenses | $38.2M | $47.5M | $34.8M | — |
| Operating income | −$38.2M | −$47.2M | −$34.5M | — |
| Operating margin | −1,050.63% | −15,777.22% | −11,796.15% | — |
| EBITDA | −$35.6M | −$44.1M | −$31.2M | — |
| EBITDA margin | −979.19% | −14,732.44% | −10,668.58% | — |
| Net income | −$38.3M | −$47.9M | −$34.6M | — |
| Net profit margin | −1,055.27% | −16,024.28% | −11,838.59% | — |
| Basic EPSper basic share | -$0.02 | -$0.12 | -$0.11 | — |
| Diluted EPSper diluted share | -$0.02 | -$0.12 | -$0.11 | — |
Owners
Reported shareholders
Reported holdings Number of shares
View holders
| Holder | Shares held |
|---|---|
Stonepine Capital Management, LLC | 51M |
HSBC HOLDINGS PLC | 62.19K |
Regal Partners Ltd | 40.14K |
PNC Financial Services Group, Inc. | 20K |
UBS Group AG | 1.51K |
Integrated Wealth Concepts LLC | 1.31K |
RHUMBLINE ADVISERS | 195 |
Bars compare reported share counts. A matching total for this share class and reporting period is unavailable, so percentages are not shown.
Source: SEC Form 13F ↗Updated Sep 29, 2026 · Quarterly data